Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Rosiglitazone and Insulin Resistance in Renally Impaired Patients

This study has been terminated.
(it was not possible to recruit new patients anymore)
Sponsor:
Information provided by:
Leiden University Medical Center
ClinicalTrials.gov Identifier:
NCT00452166
First received: March 26, 2007
Last updated: September 30, 2008
Last verified: September 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: May 2008
  Primary Completion Date: March 2008 (Final data collection date for primary outcome measure)